| 1 |
30052303 | The risk of hepatocellular carcinoma within and beyond the first 5 years of entecavir in Korean patients with chronic hepatitis B. | 2018 Dec |
1 |
| 2 |
27889576 | Incidence of Hepatocellular Carcinoma in All 50 United States, From 2000 Through 2012. | 2017 Mar |
1 |
| 3 |
28532995 | Histological subtypes of hepatocellular carcinoma are related to gene mutations and molecular tumour classification. | 2017 Oct |
1 |
| 4 |
26352789 | The management and prognosis of patients with hepatocellular carcinoma: what has changed in 20 years? | 2016 Mar |
2 |
| 5 |
26752112 | Variable Intra-Tumor Genomic Heterogeneity of Multiple Lesions in Patients With Hepatocellular Carcinoma. | 2016 Apr |
1 |
| 6 |
27128435 | Elastin Fiber Accumulation in Liver Correlates with the Development of Hepatocellular Carcinoma. | 2016 |
1 |
| 7 |
27569777 | Trends in hepatocellular carcinoma among people with HBV or HCV notification in Australia (2000-2014). | 2016 Dec |
1 |
| 8 |
24151232 | BRCA1-mediated inflammation and growth activated & inhibited transition mechanisms between no-tumor hepatitis/cirrhotic tissues and HCC. | 2014 Apr |
1 |
| 9 |
23063418 | Marginal survival benefit in the treatment of early hepatocellular carcinoma. | 2013 Feb |
1 |
| 10 |
23333348 | Prognostic gene expression signature for patients with hepatitis C-related early-stage cirrhosis. | 2013 May |
1 |
| 11 |
21354447 | Validation of the "Metroticket" predictor in a cohort of patients transplanted for predominantly HBV-related hepatocellular carcinoma. | 2011 Nov |
1 |
| 12 |
20471129 | Risk assessment for the development of hepatocellular carcinoma: according to on-treatment viral response during long-term lamivudine therapy in hepatitis B virus-related liver disease. | 2010 Jul |
1 |
| 13 |
20483498 | Incidence of hepatocellular carcinoma in chronic hepatitis B patients receiving nucleos(t)ide therapy: a systematic review. | 2010 Aug |
1 |
| 14 |
16901768 | The impact of newer treatment modalities on survival in patients with hepatocellular carcinoma. | 2006 Sep |
1 |
| 15 |
12557138 | Basal core promoter mutations of hepatitis B virus increase the risk of hepatocellular carcinoma in hepatitis B carriers. | 2003 Feb |
1 |